Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Novus Biologicals™ NALP12 Antibody Blocking Peptide
Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition
Supplier: Novus Biologicals™ NBP176293PEP
Description
A blocking peptide containing 18 amino acids near the amino terminus of human NALP12. Source: Synthetic (Accession #: NP_653288) The NALP12 Blocking Peptide has been validated for the following applications: Antibody Competition.Specifications
91662 | |
Store at -20 C. Avoid freeze-thaw cycles. | |
This Peptide is Useful as a Blocking Peptide for NBP1-76293. For Further Blocking Peptide Related Protocol, Click Here . | |
NLRP12 | |
0.05 mg | |
Synthetic |
Human | |
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin. | |
FCAS2, Monarch-1, NACHT, leucine rich repeat and PYD containing 12, NACHT, LRR and PYD domains-containing protein 12, NALP12LRR and PYD containing protein 12, NLR family, pyrin domain containing 12, nucleotide-binding oligomerization domain, leucine rich repeat and pyrin domaincontaining 12, PYPAF7Monarch1, PYRIN-containing APAF1-like protein 7, Regulated by nitric oxide, RNO2 | |
NALP12 | |
RUO - research use only | |
18 amino acids near the amino terminus of human NALP12 |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Provide Content Correction